XML 48 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information
9 Months Ended
Sep. 30, 2012
Segment Reporting [Abstract]  
Segment Information
Segment Information

The Company is organized in two operating segments, Long-Term Care Group ("LTC") and Specialty Care Group ("SCG"). These segments are based on the operations of the underlying businesses and the customers they serve. The Company's larger reportable segment is LTC, which primarily provides distribution of pharmaceuticals, related pharmacy consulting and other ancillary services and medical supplies. LTC's customers are primarily skilled nursing, assisted living and other providers of healthcare services. The Company’s other reportable segment is SCG, which provides specialty pharmacy, key commercialization services for the biopharmaceutical industry and end-of-life pharmaceutical care management for hospice care agencies. The primary components of the "Corporate/Other" segment are the Company's corporate management oversight and administration, including its information technology and data management services, as well as other consolidating and eliminating entries, which have not been charged to reportable segments. The Company evaluates the performance of its segments based on revenue and operating income, and does not include segment assets or nonoperating income/expense items for management reporting purposes.
 
 
For the three months ended September 30,
2012:
 
LTC
 
SCG
 
Corporate/Other
 
Consolidated
Totals
Net sales
 
$
1,165,703

 
$
332,615

 
$
3,030

 
$
1,501,348

Depreciation and amortization expense
 
(17,650
)
 
(4,075
)
 
(12,604
)
 
(34,329
)
Operating income (loss) from continuing operations
 
158,998

 
31,061

 
(56,328
)
 
133,731

2011:
 
 
 
 
 
 
 
 
Net sales
 
$
1,266,582

 
$
274,079

 
$
3,699

 
$
1,544,360

Depreciation and amortization expense
 
(15,851
)
 
(3,778
)
 
(13,132
)
 
(32,761
)
Operating income (loss) from continuing operations
 
126,833

 
26,424

 
(36,204
)
 
117,053

 
 
 
 
 
 
 
 
 
 
 
For the nine months ended September 30,
2012:
 
LTC
 
SCG
 
Corporate/Other
 
Consolidated
Totals
Net sales
 
$
3,664,759

 
$
956,012

 
$
9,672

 
$
4,630,443

Depreciation and amortization expense
 
(51,840
)
 
(12,134
)
 
(37,659
)
 
(101,633
)
Operating income (loss) from continuing operations
 
419,778

 
92,881

 
(188,010
)
 
324,649

2011:
 
 
 
 
 
 
 
 
Net sales
 
$
3,846,117

 
$
768,031

 
$
11,689

 
$
4,625,837

Depreciation and amortization expense
 
(47,343
)
 
(12,283
)
 
(37,700
)
 
(97,326
)
Operating income (loss) from continuing operations
 
357,104

 
72,254

 
(102,530
)
 
326,828